Marine biotechnology company focused on three areas: research, technology transfer and scientific services.

The UK's first approved investment trust dedicated to the biotechnology sector. It offers investors the means to invest in a carefully selected and diversified portfolio of biotechnology companies. As part of its investment policy, IBT provides strategic and scientific support to the companies in which it invests.

Online information service for professionals in the bio-pharma and high-tech arenas.

Cell Based Biosensors - Utilizes innovations in human gene transcription technology to develop advanced ultrasensitive, high-throughput, cell-based biosensors.

Researching the mechanisms of immunosuppression and tolerance, to develop new medicines for immunological and inflammatory diseases.

Provides biochips and information products.

Develops targeted drugs and non-viral gene delivery systems. Also, specialized in enhanced oxygen to cells treatments.

Offers contract services in the fields of genomics, combinatorial chemistry and biopharmaceuticals. Lists company information and publications.

Specializing in research and production of plant-derived recombinant therapeutic proteins.

Uses morphogenics to expedite the evolutions of organisms, such as plants and yeast, to obtain commercially useful output traits.

Products and services include molecular biology instruments, DNA sequencing, oligos, microarrays, and bioinformatics.

Develops and commercializes new recombinant proteins from transgenic plants.

Uses transgenetic goats milk to produce therapeutic proteins and biomaterials to treat serious diseases. Located in Canada.

Develops immunodiagnostic products to identify diseases affecting bone and cartilage.

Created by the merger of Ciba and Sandoz. Has core businesses in healthcare, agribusiness and consumer health.